From complexity to cohesion: AI’s growing role in building s...
AI is being used from protocol design to study start-up and through clinical trial closeout, reshaping the trial lifecycle.
Newsletters and Deep Dive digital magazine
AI is being used from protocol design to study start-up and through clinical trial closeout, reshaping the trial lifecycle.
Chronic skin conditions, particularly CHE, remain some of the most underestimated, yet pervasive, challenges affecting people across Europe.
Andrew Newland, CEO of ANGLE, explains why live cell liquid biopsies should become standard in oncology.
With stronger foundations and a growing national appetite for change, 2026 could be the year when unified data becomes routine practice.
Digital systems are steadily replacing legacy software and automation tools roll out at speed to cut back the time clinicians spend on manual tasks.
Editor's Picks
Newsletters and Deep Dive
digital magazine